← Back to Search

Unrelated healthy controls for Wilson's Disease

N/A
Recruiting
Research Sponsored by Wan-Jin Chen
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 30years
Awards & highlights

Summary

This trial is testing a new way to manage Wilson's Disease, a rare genetic disorder that causes copper to build up in the body.

Eligible Conditions
  • Wilson's Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 30years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 30years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The change of Unified Wilson's Disease Rating Scale (UWDRS)

Trial Design

4Treatment groups
Experimental Treatment
Group I: Unrelated healthy controlsExperimental Treatment1 Intervention
Group II: Relatives of Wilson's Disease patients or carriersExperimental Treatment1 Intervention
Group III: Patients with the genetic diagnosis of Wilson's DiseaseExperimental Treatment1 Intervention
Group IV: Asymptomatic Wilson's Disease carriersExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Wan-Jin ChenLead Sponsor
4 Previous Clinical Trials
5,402 Total Patients Enrolled
~1333 spots leftby Dec 2039